EKF Diagnostics Holdings plc provided earnings guidance for the year 2021. After multiple upgrades last year and a step change in year-on-year performance, the announcement in March of a multi-million dollar contract expansion for the supply of sample collection devices to a large multinational customer drove a further material upgrade to revenue expectations and a significant one for profit for 2021. The March upgrades were based just on visible orders under the supply agreement and a continuing conservative approach to forecasting on the core business. Strong trading continues into the second quarter 2021 and the Board is now confident that trading for the full year will be comfortably ahead of already upgraded management expectations.